The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwMyeloma 2017 | Exciting new developments in multiple myeloma
This is an incredibly exciting time for multiple myeloma (MM) research. In this video, some of the most interesting topics presented at the Myeloma 2017 meeting in Edinburgh, UK, are discussed by Daniel Auclair, Senior Vice President of Research, MMRF, Irene Ghobrial, MD, from the Dana-Farber Cancer Institute, Boston, MA, Jonathan Keats, PhD, of the Translational Genomics Research Institute, Phoenix, AZ, Nina Shah, MD, of UCSF Medical Center, San Francisco, CA and Larry Boise, PhD, from Emory University School of Medicine, Atlanta, GA. The developing reality of liquid biopsies, emerging novel subtypes of MM, ground-breaking advances in immunotherapies and exciting improvements in the understanding of resistance mechanisms are discussed. The experts interviewed also provide an overview of the techniques that we could soon see transitioned into clinical use.
